A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy

Clinical trial NCT00238654 · COMPLETED

Trial details

NCT number: NCT00238654
Sponsor: Teva Neuroscience, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis

Start date: 2003-05-01
Primary completion: 2008-07-01
Enrollment: 257

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.